Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update for a vaccine therapy in patients with stage I-IIIA non-small cell lung cancer or stage I-II malignant mesothelioma. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma
• Non-small Cell Lung Cancer

Drugs mentioned

• Vaccine therapy

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Lung Cancer, Malignant Mesothelioma | Phase 1 | Status: COMPLETED